Serum vitamin E concentration in Iranian population with angiography defined coronary artery disease

1. Steinberg D, Lewis A, Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis. Circulation. 1997; 95:1062-71.10.1161/01.CIR.95.4.1062Search in Google Scholar

2. Parks EJ, German JB, Davis PA, et al. Reduced oxidative susceptibility of LDL from patients participating in an intensive atherosclerosis treatment program. Am J Clin Nutr. 1998; 68:778-85.10.1093/ajcn/68.4.778Search in Google Scholar

3. Chan CA. Vitamin E and Atherosclerosis. The Journal of Nutrition. 1998; 128:1593-6.10.1093/jn/128.10.1593Search in Google Scholar

4. Dutta A, Dutta KS. Vitamin E and its Role in the Prevention of Atherosclerosis and Carcinogenesis: A Review. Journal of the American College of Nutrition. 2003; 22:258-68.10.1080/07315724.2003.10719302Open DOISearch in Google Scholar

5. Upston JM, Terentis AC, Stocker R. Tocopherolmediated peroxidation of lipoproteins: implications for vitamin E as a potential anti-atherogenic supplement. The FASEB Journal. 1999; 13:977-94.10.1096/fasebj.13.9.977Search in Google Scholar

6. Regnstrom J, Nilsson J, Moldeus P, Strom K, Bavenholm P, Tornvall P , Hamsten A. Inverse relation between the concentration of low-density-lipoprotein vitamin E and severity of coronary artery disease. Am J Clin Nutr. 1996; 63:377-85.10.1093/ajcn/63.3.377Search in Google Scholar

7. Gey KF, Pushka P, Jordan P, Moser UK. Inverse correlation between plasma vitamin E and mortality from ischemic heart diseases in cross cultural epidemiology. Am J Clin Nutr. 1991; 53:326-34.10.1093/ajcn/53.1.326SSearch in Google Scholar

8. Feki M, Souissi M, Mokhtar E, Hsairi M, Kaabachi N, Antebi H, et al. Vitamin E and coronary heart disease in Tunisians. Clinical Chemistry. 2000; 46:1401-5.10.1093/clinchem/46.9.1401Search in Google Scholar

9. Haidari M, Javadi E, Kadkhodaee M, Sanati A. Enhanced susceptibility to oxidation and diminished vitamin E content of LDL from patients with stable coronary artery disease. Clinical Chemistry. 2001; 47: 1234-40.10.1093/clinchem/47.7.1234Search in Google Scholar

10. Salonen JT, Salonen R, Penttila I, Herranen J, Jauhiainen M, Kantola M. Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and risk of death from coronary artery diseases. Am J Cardiol. 1985; 56:226-31.10.1016/0002-9149(85)90839-2Search in Google Scholar

11. Kok F, De Bruijn AM, Vermeeren R, Hoffman A, Van Laar A, De Bruin M, et al. Serum selenium and vitamin antioxidants and cardiovascular mortality. Am J Clin Nutr. 1987; 45:462-8.10.1093/ajcn/45.2.4623812345Search in Google Scholar

12. Street DA, Comstock GW, Salkled RM, Sch­ep W, Klag MJ. A population-based case-control study of the association between serum antioxidant and myocardial infarction. Am J Epidemiol. 1991; 134: 719-20.Search in Google Scholar

13. Ohrvall M, Berghund L, Salmmeri I, Lithell H, Aro A, Vessby B. The serum cholesterol and essential fatty acid composition but not alpha tocopherol predicts the development of myocardial infarction in 50-yearold-men: a 9 years follow up. Atherosclerosis. 1996;127:65-71.10.1016/S0021-9150(96)05936-9Search in Google Scholar

14. Ghayour-Mobarhan M, Sahebkar AH, Livingstone C, Wang T, Lamb D, Ferns G. An investigation of the relationship between serum vitamin E status and coronary risk factors in dyslipidaemic patients. Iranian Journal of Biomedical Science. 2008; 10:206-15.Search in Google Scholar

15. Sarraf-Zadegan N, Seyed-Tabatabaei FA, Bashardoost N, Malek A, Totonchi M, Habibi HR, et al. The prevalence of coronary artery disease in an urban population in Isfahan, Iran. Acta Cardiol. 1999: 54:257-63.Search in Google Scholar

16. Hatmi ZN, Tahvildari S, Gafarzadeh Motlag A, Sabouri Kashani A. Prevalence of coronary artery disease risk factors in Iran: a population based survey. BMC cardiovascular Disorder [on line] 2007 [cited 2007]; 7:32, Available from: http://www.biomedcentral.com/1471-2261/7/32.10.1186/1471-2261-7-32Search in Google Scholar

17. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med. 1993; 328:1450-6.10.1056/NEJM199305203282004Search in Google Scholar

18. Rajasekhar D, Srinivasa Rao P, Latheef S, Saibaba K, Subramanyam G. Association of serum antioxidants and risk of coronary heart disease in South Indian population. Indian Journal of Medical Sciences. 2004; 58:465-71.Search in Google Scholar

19. Salonen JT, Salonen R, Penttila I, et al. Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease. Am J Cardiol. 1985; 56:226-31.10.1016/0002-9149(85)90839-2Search in Google Scholar

20. Kok FJ, de Bruijn AM, Vermeeren R, et al. Serum selenium, vitamin antioxidants and cardiovascular mortality: A 9-year follow-up study in the Netherlands. Am J Clin Nutr. 1987; 45:462-8.10.1093/ajcn/45.2.462Search in Google Scholar

21. Evans RW, Shaten BJ, Day BW, Kuller LH. Prospective association between lipid soluble antioxidants and coronary heart disease in men. The Multiple Risk Factor Intervention Trial. Am J Epidemiol. 1998; 147:180-6.10.1093/oxfordjournals.aje.a0094329457009Search in Google Scholar

22. Kushi LH, Folsom AR, Prineas RJ, Mink PJ, Wu Y, Bostick RM. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med. 1996; 334:1156-62.10.1056/NEJM1996050233418038602181Search in Google Scholar

23. Pham DQ, Plakogiannis R. Vitamin E supplementation in cardiovascular disease and cancer prevention. The Annals of Pharmacotherapy. 2005; 39:1870-78.10.1345/aph.1G21116189282Open DOISearch in Google Scholar

24. Riccioni G, Bucciarelli T, Mancini B, Corradi F, Di Ilio C, Mattei PA , D’Orazio N. Antioxidant Vitamin Supplementation in Cardiovascular Diseases. Annals of Clinical Laboratory Science. 2007; 37:89-95.Search in Google Scholar

25. Schwenke DC, Rudel LL, Sorci-Thomas MG, Thomas MJ. α-tocopherol protects against diet induced atherosclerosis in New Zealand white rabbits. Journal of Lipid Research. 2002; 43:1927-38.10.1194/jlr.M200261-JLR200Search in Google Scholar

26. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSIPrevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infartomiocardico. Lancet. 1999; 354:447-55.10.1016/S0140-6736(99)07072-5Search in Google Scholar

27. Collaborative Group of the Primary Prevention Project. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomized trial in general practice. Lancet 2001; 357:89-95.10.1016/S0140-6736(00)03539-XSearch in Google Scholar

28. Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000; 342:154-60.Search in Google Scholar

29. Miller III ER, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality. Annals of Internal Medicine. 2005; 142: 37-46.10.7326/0003-4819-142-1-200501040-0011015537682Search in Google Scholar

30. Kinlay S, Behrendt D, Fang JC, Delagrange D, Morrow J, Witztum JL, Rifai N, Selwyn AP, Creager MA, Ganz P. Long-Term Effect of Combined Vitamins E and C on Coronary and Peripheral Endothelial Function. J Am Coll Cardiol. 2004; 43:629-34.10.1016/j.jacc.2003.08.05114975474Search in Google Scholar

31. Keith ME, Keith ME, Jeejeebhoy KN, Langer A, Kurian R, Barr A, et al. A controlled clinical trial of vitamin E supplementation in patients with congestive heart failure. Am J Clin Nutr 2001; 73:219-24.10.1093/ajcn/73.2.21911157316Search in Google Scholar

32. Ferns GAA. Multiple step-variable pathway hypothesis: A reason why predictions fail in atherosclerosis. Medical Hypotheses. 2008; 71:923-6.10.1016/j.mehy.2008.07.01418762385Search in Google Scholar

33. Stocker R, Keaney JF. Role of oxidative modifications in atherosclerosis. Physiol Rev. 2004; 84:1381-478.10.1152/physrev.00047.200315383655Search in Google Scholar

34. Manson JE, Bassuk SS, Stampfer MJ. Does vitamin E supplementation prevent cardiovascular events? J Womens Health (Larchmt). 2003; 12:123-36.10.1089/15409990332157651012741415Open DOISearch in Google Scholar

35. Reitman A, Friedrich I, Ben-Amotz A, Levy Y. Low Plasma Antioxidants and Normal Plasma B Vitamins and Homocysteine in Patients with Severe Obesity. IMAJ. 2002; 4:590-3.Search in Google Scholar

36. Brown M. Do vitamin E and fish oil protect against ischemic heart disease? Lancet. 1999; 354:441-2.Search in Google Scholar

37. Schectman G, Byrd JC, Gruchow HW. The influence of smoking on vitamin C status in adults. Am J Public Health. 1989; 79:158-62.10.2105/AJPH.79.2.158Open DOISearch in Google Scholar

38. Karajibani M, Hashemi M, Montazerifar F, Bolouri A, Dikshit M.The status of glutathione peroxidase, superoxide desmutase, vitamins A, C, E and malondialdehyde in patients with cardiovascular disease in Zahedan, South Iran. J Nutri Sci Vitaminol. 2009; 55:309-16.10.3177/jnsv.55.30919763031Open DOISearch in Google Scholar

39. Aliabadi M, Kimiagar M, Ghayour-Mobarhan M, Shakeri MT, Nematy M, Ilaty AA, et al. Prevalence of malnutrition in free living elderly people in Iran: a crosssectional study. Asia Pac J Clin Nutr. 2008; 17:285-9.Search in Google Scholar

40. Palli D, Decarli A, Russo A, Cipriani F, Giacosa A, Amadori D, et al. Plasma levels of antioxidant vitamins and cholesterol in a large population sample in centralnorthern Italy. Eur J Nutr. 1999; 38:90-8.10.1007/s00394005004910352948Open DOISearch in Google Scholar